Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month […]
Innovis Asset Management LLC lifted its stake in Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 266.1% in the third quarter, HoldingsChannel reports. The firm owned 38,501 shares of the biopharmaceutical company’s stock after purchasing an additional 27,984 shares during the period. Innovis Asset Management LLC’s holdings in Revance Therapeutics were worth $442,000 at the […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) shares shot up 12.5% during mid-day trading on Tuesday . The company traded as high as $5.81 and last traded at $5.74. 615,845 shares changed hands during mid-day trading, a decline of 62% from the average session volume of 1,640,345 shares. The stock had previously closed at […]
On Jan. 23, St. Luke Catholic Elementary School teacher Kate Winn was thrilled to be part of a press release with Education Minister Stephen Lecce, bringing the Peterborough Victoria Northumberland and Clarington (PVNC) Catholic District School Board into the public eye.
By Chris Wack Revance Therapeutics said Friday that the U.S. Centers for Medicare & Medicaid Services has assigned a permanent J-code for Daxxify,.